Latest European Patent Organisation Stories
MUNICH, January 22, 2015 /PRNewswire/ -- - Europe's most prestigious innovation prize celebrates its tenth year - The European Patent Office to present
MONCHENGLADBACH, Germany and NINGBO, China, Nov. 27, 2014 /PRNewswire/ -- Ningbo Signatronic Technologies, Ltd., and TaLa UG & Co.
MELBOURNE, Australia and BARCELONA, October 31, 2014 /PRNewswire/ -- Multigate Medical Devices Pty Ltd (Multigate) was found to infringe two Australian patents of B.
TAIPEI, July 29, 2014 /PRNewswire/ -- Apex Medical Corporation (Apex, TWSE: 4106), a leading player in the Respiratory Therapy and Pressure Area Care sectors, announces that it is appealing
JENA, Germany, July 23, 2014 /PRNewswire/ -- Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced
Copan’s attack was blown away by the District Court Düsseldorf. Guilford, ME (PRWEB) July 17, 2014 At an oral hearing on June 24, 2014 (case no.
HAMM, Germany, May 9, 2014 /PRNewswire/ -- In December 2011, Align Technology filed a patent infringement lawsuit against Ortho Caps GmbH (maker of orthocaps(R) aligners)
LONDON and MUNICH, April 29, 2014 /PRNewswire/ -- - Toumazou developed game-changing rapid "do-it-yourself" DNA test - Microchip instead of genetics
BEIJING, April 23, 2014 /PRNewswire/ -- BMC Medical Co., Ltd (in the following: BMC) announces that BMC has initiated invalidity proceedings in China against five ResMed's patents before the
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...